Willner & Heller’s Gilead Sciences GILD Stock Holding History

Willner & Heller’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$648K	Buy	5,130 +32	+0.6%	+$4.22K	0.41%	74
2026 Q1	$710K	Buy	5,098 +31	+0.6%	+$4.34K	0.53%	56
2025 Q4	$622K	Sell	5,067 -211	-4%	-$25.6K	0.45%	67
2025 Q3	$586K	Buy	5,278 +37	+0.7%	+$4.21K	0.45%	74
2025 Q2	$581K	Buy	5,241 +87	+2%	+$9.26K	0.49%	68
2025 Q1	$577K	Buy	5,154 +37	+0.7%	+$3.82K	0.53%	60
2024 Q4	$473K	Buy	5,117 +42	+0.8%	+$3.78K	0.41%	82
2024 Q3	$425K	Sell	5,075 -1,228	-19%	-$93.7K	0.38%	89
2024 Q2	$432K	Buy	6,303 +2,174	+53%	+$145K	0.41%	82
2024 Q1	$302K	Buy	+4,129	New	+$318K	0.3%	111

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Willner & Heller's GILD Position: Q2 2026 in Review

Willner & Heller increased its Gilead Sciences (GILD) stake by 0.63% in Q2 2026, buying an estimated $4.22K and bringing the position to 5,130 shares worth $648K. The position accounts for 0.41% of the portfolio, ranked #74.

Willner & Heller first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. The position peaked at $710K in Q1 2026. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Willner & Heller held 5,130 shares of Gilead Sciences worth $648K as of Q2 2026.
Willner & Heller bought 32 Gilead Sciences shares in Q2 2026, an estimated $4.22K.
Gilead Sciences made up 0.41% of Willner & Heller's portfolio in Q2 2026, its #74 holding.
Willner & Heller first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
Willner & Heller's Gilead Sciences position peaked at $710K in Q1 2026.
361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Willner & Heller's 13F filing for Q2 2026, filed 7 Jul 2026.